CRSP - BioLineRx stock jumps 14% on St. Jude clinical trial for mitoxafortide May, 30 2024 01:54 PM CRISPR Therapeutics AG 2024-05-30 13:54:38 ET More on biolinerx BioLineRx Ltd. (BLRX) Q1 2024 Earnings Call Transcript BioLineRx Ltd. (BLRX) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on biolinerx Historical earnings data for biolinerx Financial information for biolinerx For further details see: BioLineRx stock jumps 14% on St. Jude clinical trial for mitoxafortide